Vincerx Pharma
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -270 | -264 | ||
EBITDA | -7,518 | -7,096 | -7,214 | |
EBIT | -7,793 | -7,366 | -7,478 | |
Net Income | -7,994 | -7,843 | -1,808 | -12,429 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -6,181 | -6,379 | -5,828 | -7,739 |
Cash | 4,987 | 2,942 | 8,005 | 5,192 |
Basic Shares | 2,239 | 45,672 | 38,339 | 21,400 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -915 | -939 | -340 | |
EBITDA | -31,463 | -42,609 | -68,668 | -62,656 |
EBIT | -42,661 | -69,607 | -62,996 | |
Net Income | -30,074 | -40,157 | -57,160 | -15,608 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -26,127 | -40,453 | -59,604 | -38,660 |
Cash | 4,987 | 12,782 | 11,663 | 111,459 |
Basic Shares | 1,898 | 21,295 | 21,029 | 17,176 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-03-31 | -$3.56 |
2024-09-30 | -$0.17 |
2024-06-30 | -$0.05 |
2024-03-31 | -$0.58 |
